Sansure Biotech (SHSE:688289) COGS-to-Revenue : 0.19 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech COGS-to-Revenue?

Sansure Biotech's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥74 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥391 Mil.

Sansure Biotech's COGS to Revenue for the three months ended in Mar. 2024 was 0.19.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sansure Biotech's Gross Margin % for the three months ended in Mar. 2024 was 81.10%.

Sansure Biotech COGS-to-Revenue Historical Data

The historical data trend for Sansure Biotech's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sansure Biotech COGS-to-Revenue Chart

Sansure Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.35

0.20

0.28

0.41

0.28

Sansure Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.33	0.34	0.27	0.24	0.19

Sansure Biotech COGS-to-Revenue Calculation

Sansure Biotech's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	286.641	/	1007.119
	=	0.28

Sansure Biotech's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	73.904	/	390.947
	=	0.19

Sansure Biotech (SHSE:688289) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sansure Biotech's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	73.904 / 390.947
	=	81.10 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sansure Biotech COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sansure Biotech (SHSE:688289) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205

Website

http://www.sansure.com.cn

Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.

Sansure Biotech (SHSE:688289) Headlines

No Headlines